Results 181 to 190 of about 231,974 (295)

Polymorphic variants involved in methylation regulation: a strategy to discover risk loci for pancreatic ductal adenocarcinoma [PDF]

, 2023
Chiara Corradi, Giulia Lencioni, Manuel Gentiluomo, Alessio Felici, Anna Latiano, Gediminas Kiudelis, Casper H.J. van Eijck, Komang Andika Marta, Rita T. Lawlor, Francesca Tavano, Ugo Boggi, Frederike Dijk, Giulia Martina Cavestro, Roel Vermeulen, Thilo Hackert, Maria Chiara Petrone, Faik G. Uzunoǧlu, Lívia Archibugi, Jakob R. Izbicki, Luca Morelli, Alessandro Zerbi, Stefano Landi, Hannah Stocker, Renata Talar‐Wojnarowska, Gregorio Di Franco, Péter Hegyi, Cosimo Sperti, Silvia Carrara, Gabriele Capurso, Maria Gazouli, Hermann Brenner, Ștefania Bunduc, Olivier R. Busch, Francesco Perri, Martin Oliverius, Péter Jenő Hegyi, Mara Göetz, Pasquale Scognamiglio, Andrea Mambrini, Paolo Giorgio Arcidiacono, Edita Kreivėnaitė, Juozas Kupčinskas, Tamás Hussein, Stefano Ermini, Anna Caterina Milanetto, Pavel Vodička, Vytautas Kiudelis, Viktor Hlaváč, Pavel Souček, George Theodoropoulos, Daniela Basso, John P. Neoptolemos, Mateus Nóbrega Aoki, Raffaele Pezzilli, Claudio Pasquali, Roger Chammas, Sabrina Gloria Giulia Testoni, Beatrice Mohelníková-Duchoňová, M Lucchesi, Cosmeri Rizzato, Federico Canzian, Daniele Campa   +61 more
openalex   +1 more source

Mitochondrial Metabolism in Pancreatic Ductal Adenocarcinoma: From Mechanism-Based Perspectives to Therapy [PDF]

, 2023
Hafiza Padinharayil, Vikrant Rai, Alex George   +2 more
openalex   +1 more source

pH-Dependent Microenvironmental Ionic Signaling in Pancreatic Ductal Adenocarcinoma. [PDF]

Acta Physiol (Oxf)
Schwab A, Rugi M, Swietach P, Błaszczak W, Novak I, Deshar G, Pedersen SF, Ialchina R, Sandelin A, Yao J, Reshkin SJ, Cardone RA, Carvalho TMA, Arcangeli A, Bouazzi R, D'Alessandro FN, Prevarskaya N, Audero MM, Ouadid-Ahidouch H, Schnipper J, Pardo LA, Shi X, Alves F, Mitręga J, Trauzold A, Hagelund SE, Panyi G, Cozzolino M, Löwik CMWG, Mezzanotte L, McMorrow R, Pahl A, Hechler T, Papacharisi E, Pla AF, Szabo I, Hofschröer V, Pethő Z.   +37 more
europepmc   +1 more source

Intratumoral CD38+CD19+B cells associate with poor clinical outcomes and immunosuppression in patients with pancreatic ductal adenocarcinoma [PDF]

Heng Zhu, Jin Xu, Wei Wang, Bo Zhang, Jiang Liu, Chen Liang, Jie Hua, Qingcai Meng, Xianjun Yu, Si Shi   +9 more
openalex   +1 more source

KRAS Inhibition in Pancreatic Ductal Adenocarcinoma. [PDF]

J Clin Med
Pradeep R, Isbeih NJ, Abraham FF, Noori E, Yeung ZP, Kundranda MN.   +5 more
europepmc   +1 more source

Octyl Gallate Induces Pancreatic Ductal Adenocarcinoma Cell Apoptosis and Suppresses Endothelial-Mesenchymal Transition-Promoted M2-Macrophages, HSP90α Secretion, and Tumor Growth [PDF]

, 2019
Kee Voon Chua, Chi-Shuan Fan, Chia‐Chi Chen, Lili Chen, Shu‐Chen Hsieh, Tze‐Sing Huang   +5 more
openalex   +1 more source

NADK is activated by oncogenic signaling to sustain pancreatic ductal adenocarcinoma. Schild et al.

, 2021
Tanya Schild
openalex   +1 more source

Epigenetic Regulators as Therapeutic Targets in Pancreatic Ductal Adenocarcinoma. [PDF]

Cancers (Basel)
Kubiak K, Inkielewicz-Stępniak I.
europepmc   +1 more source

A mucus production programme promotes classical pancreatic ductal adenocarcinoma [PDF]

Claudia Tonelli, Georgi N. Yordanov, Yuan Hao, Astrid Deschênes, Juliene Hinds, Pascal Belleau, Olaf Klingbeil, Erin Brosnan, Abhishek Doshi, Youngkyu Park, Ralph H. Hruban, Christopher R. Vakoc, Alexander Dobin, Jonathan Preall, David A. Tuveson   +14 more
openalex   +1 more source

Treating Pancreatic Ductal Adenocarcinoma: The Targeted Revolution is Here. [PDF]

Drugs
May MS, Park W, O'Reilly EM.
europepmc   +1 more source